SOURCE: RoboticOncology.com

January 10, 2008 09:00 ET

Prostate Cancer Treatment Expert David B. Samadi, MD Announces New International Web Portal

NEW YORK, NY--(Marketwire - January 10, 2008) - Dr. David B. Samadi announces a new interactive site for patients and surgeons on treatments for prostate and other urologic cancers. He calls it "patient friendly and educational for urologists as well." Improvements in the website include the patient forum and blog, where people can ask questions and share their prostate cancer treatment experiences. This is an innovation in the healthcare profession and treatment of urologic cancers. The website is international and available in the following languages: English, Spanish, French, Italian, German, and Russian.

It is Dr. Samadi's intention that these features will serve to educate the patient community and their families about the benefits of da Vinci prostate surgery and his proven surgical expertise. Active participation in the forum and blog components augment the goals of the site.

Dr. Samadi is proud to point out that his surgical team handles 45 to 50 new cases per month. In the past 6 months, he has performed over 330 prostate cancer treatment cases. The team is constantly fine-tuning its approach so that each patient benefits from the collective knowledge of the team. However, all of the robotic surgeries are performed by Dr. Samadi from beginning to end.

When asked what makes his team so successful, he responds: "I work with an established team, from scrub nurses to anesthesiologists to surgeons. The coordination among these individuals is second to none. We have been in so many difficult surgeries that we trust each other completely and know how to react to changing situations in the operating room."

He refers to the past, present, and future of his commitment to curing prostate cancer. Dr. Samadi points out what his group has done, where it is now, and what the future holds for Urologic Oncology. However, all roads lead to most surgeries being performed robotically with the da Vinci system. This is because robotic surgery facilitates treatment of the most challenging and complex cancers with minimal post operative complications and superior oncologic outcomes.

About David B. Samadi MD & RoboticOncology.com

David B. Samadi, MD is Chief of Robotic Surgery and Minimal Invasive Surgery at Mount Sinai School of Medicine in New York City. He is a board certified Urologic Oncologist, specializing in the diagnosis and treatment of bladder, kidney, and prostate cancer using minimally invasive procedures like da Vinci surgery. If you would like more information about Dr. Samadi's state-of-the-art treatment options, including the robotic prostatectomy, please don't hesitate to call his office at 212-241-8779, or visit him on the web at http://www.roboticoncology.com.

Contact Information

  • Contact:
    David B. Samadi
    Chief, Division of Robotics and Minimal Invasive Surgery
    Mount Sinai School of Medicine
    212-241-8779